| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.471 | 0.035 | 0.471 | Vasodilator, peripheral | |||
| 0.408 | 0.02 | 0.408 | DNA synthesis inhibitor | 0.401 0.021 DBMET00463 | ||
| 0.34 | 0.025 | 0.4 | RNA-directed DNA polymerase inhibitor | 0.4 0.018 DBMET00463 | DBMET00463 | |
| 0.353 | 0.044 | 0.353 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.361 | 0.056 | 0.361 | Immunomodulator | |||
| 0.339 | 0.093 | 0.346 | Immunosuppressant | 0.346 0.089 DBMET00463 | DBMET00463 | |
| 0.3 | 0.078 | 0.3 | Immunostimulant | 0.273 0.087 DBMET00463 | ||
| 0.197 | 0.006 | 0.197 | Interferon agonist | 0.085 0.045 DBMET00463 | ||
| 0.287 | 0.099 | 0.287 | Vasodilator, coronary | |||
| 0.187 | 0.011 | 0.187 | DNA repair enzyme inhibitor | 0.128 0.058 DBMET00463 | ||
| 0.247 | 0.076 | 0.247 | Tumour necrosis factor alpha release inhibitor | |||
| 0.18 | 0.013 | 0.18 | Adenosine A2 receptor antagonist | |||
| 0.228 | 0.063 | 0.228 | Platelet aggregation inhibitor | |||
| 0.191 | 0.027 | 0.191 | Adenylate cyclase inhibitor | 0.145 0.048 DBMET00463 | ||
| 0.171 | 0.014 | 0.171 | ErbB-3 antagonist | |||
| 0.184 | 0.033 | 0.332 | DNA polymerase I inhibitor | 0.332 0.009 DBMET00463 | DBMET00463 | |
| 0.162 | 0.014 | 0.162 | Adenosine A2a receptor antagonist | |||
| 0.153 | 0.004 | 0.153 | Interferon inducer | 0.071 0.033 DBMET00463 | ||
| 0.302 | 0.162 | 0.302 | 5 Hydroxytryptamine release inhibitor | 0.249 0.229 DBMET00463 | ||
| 0.164 | 0.035 | 0.164 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.147 | 0.023 | 0.147 | Folate antagonist | |||
| 0.135 | 0.015 | 0.135 | CDK1/cyclin B inhibitor | |||
| 0.147 | 0.031 | 0.147 | CDK/cyclin complex inhibitor | |||
| 0.179 | 0.064 | 0.179 | MAP kinase kinase 5 inhibitor | 0.158 0.123 DBMET00463 | ||
| 0.155 | 0.046 | 0.155 | Interleukin 4 antagonist | |||
| 0.118 | 0.018 | 0.118 | Cyclin E inhibitor | |||
| 0.116 | 0.02 | 0.116 | Adenosine A1 receptor antagonist | 0.051 0.048 DBMET00463 | ||
| 0.105 | 0.009 | 0.105 | Heat shock protein 90 beta antagonist | |||
| 0.2 | 0.104 | 0.2 | Vasodilator | 0.164 0.138 DBMET00463 | ||
| 0.098 | 0.006 | 0.098 | Adenosine deaminase inhibitor | 0.09 0.007 DBMET00463 | ||
| 0.245 | 0.159 | 0.245 | Histamine release inhibitor | |||
| 0.088 | 0.003 | 0.089 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.089 0.003 DBMET00463 | DBMET00463 | |
| 0.108 | 0.026 | 0.108 | Purinergic P2X2 antagonist | |||
| 0.15 | 0.07 | 0.15 | CDC-like kinase 1 inhibitor | |||
| 0.105 | 0.026 | 0.105 | CDK2/cyclin E2 inhibitor | |||
| 0.143 | 0.067 | 0.143 | Toll-Like receptor 9 antagonist | |||
| 0.082 | 0.008 | 0.115 | Thymidine kinase inhibitor | 0.115 0.005 DBMET00463 | DBMET00463 | |
| 0.086 | 0.013 | 0.086 | Adenosine A2b receptor antagonist | |||
| 0.136 | 0.064 | 0.136 | Cyclin-dependent kinase inhibitor | |||
| 0.092 | 0.021 | 0.092 | Cyclin E1 inhibitor | |||
| 0.112 | 0.043 | 0.112 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.146 | 0.083 | 0.146 | CF transmembrane conductance regulator agonist | |||
| 0.098 | 0.036 | 0.098 | mTOR complex 2 inhibitor | |||
| 0.078 | 0.016 | 0.078 | Cyclin B inhibitor | |||
| 0.081 | 0.021 | 0.081 | Cyclin B1 inhibitor | |||
| 0.163 | 0.103 | 0.163 | Clk dual-specificity kinase inhibitor | |||
| 0.072 | 0.013 | 0.072 | Nicotinic acid receptor 1 agonist | 0.061 0.015 DBMET00463 | ||
| 0.231 | 0.172 | 0.231 | GABA C receptor rho-3 antagonist | |||
| 0.119 | 0.061 | 0.119 | Transcription factor STAT6 inhibitor | |||
| 0.144 | 0.087 | 0.144 | Src kinase inhibitor | |||
| 0.127 | 0.07 | 0.127 | c-Src kinase inhibitor | |||
| 0.09 | 0.033 | 0.09 | Cyclin B3 inhibitor | |||
| 0.1 | 0.045 | 0.1 | Polo-like kinase-1 inhibitor | |||
| 0.072 | 0.02 | 0.072 | Cyclin B2 inhibitor | |||
| 0.087 | 0.035 | 0.087 | Adenosine A3 receptor antagonist | |||
| 0.07 | 0.019 | 0.07 | Histamine agonist | |||
| 0.079 | 0.031 | 0.079 | CDK2/cyclin E inhibitor | |||
| 0.069 | 0.023 | 0.069 | Cyclin A1 inhibitor | |||
| 0.059 | 0.014 | 0.059 | Cytokine production stimulant | |||
| 0.067 | 0.023 | 0.067 | Antimetabolite | 0.057 0.027 DBMET00463 | ||
| 0.074 | 0.036 | 0.074 | Cyclin A2 inhibitor | |||
| 0.12 | 0.084 | 0.12 | Toll-Like receptor antagonist | |||
| 0.108 | 0.072 | 0.108 | Platelet activating factor antagonist | |||
| 0.071 | 0.037 | 0.071 | Cyclin A inhibitor | |||
| 0.1 | 0.069 | 0.1 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.036 | 0.006 | 0.04 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.04 0.005 DBMET00463 | DBMET00463 | |
| 0.079 | 0.049 | 0.079 | MAP kinase 7 inhibitor | |||
| 0.139 | 0.11 | 0.139 | CDC-like kinase 4 inhibitor | |||
| 0.061 | 0.033 | 0.061 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.05 0.049 DBMET00463 | ||
| 0.093 | 0.065 | 0.093 | CDK2/cyclin A inhibitor | |||
| 0.089 | 0.061 | 0.089 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.094 | 0.067 | 0.094 | Electrolyte absorption antagonist | |||
| 0.096 | 0.07 | 0.096 | mTOR complex 1 inhibitor | |||
| 0.071 | 0.046 | 0.071 | CDK1/cyclin B1 inhibitor | 0.064 0.055 DBMET00463 | ||
| 0.033 | 0.01 | 0.048 | DNA polymerase III inhibitor | 0.048 0.004 DBMET00463 | DBMET00463 | |
| 0.136 | 0.113 | 0.136 | Antipruritic | |||
| 0.151 | 0.13 | 0.151 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.073 | 0.052 | 0.073 | Glutamate dehydrogenase inhibitor | |||
| 0.025 | 0.004 | 0.031 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.031 0.003 DBMET00463 | DBMET00463 | |
| 0.136 | 0.118 | 0.136 | Tumour necrosis factor antagonist | |||
| 0.058 | 0.041 | 0.058 | Cyclin H inhibitor | |||
| 0.167 | 0.151 | 0.167 | Interleukin agonist | |||
| 0.022 | 0.011 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.01 DBMET00463 | DBMET00463 | |
| 0.019 | 0.007 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.012 DBMET00463 | ||
| 0.015 | 0.005 | 0.018 | Purine nucleoside phosphorylase inhibitor | 0.018 0.004 DBMET00463 | DBMET00463 | |
| 0.049 | 0.04 | 0.049 | Ornithine carbamoyltransferase inhibitor | |||
| 0.138 | 0.13 | 0.138 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.011 | 0.003 | 0.022 | DNA polymerase III subunit alpha inhibitor | 0.022 0.002 DBMET00463 | DBMET00463 | |
| 0.166 | 0.162 | 0.166 | Nitric-oxide synthase stimulant | |||
| 0.16 | 0.155 | 0.16 | ErbB-1 antagonist | |||
| 0.089 | 0.085 | 0.089 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.112 | 0.111 | 0.112 | Cell wall synthesis inhibitor | |||
| 0.053 | 0.052 | 0.053 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.011 | 0.025 | 0.013 | DNA polymerase III polC-type inhibitor | 0.013 0.01 DBMET00463 | DBMET00463 | |
| 0.191 | 0.235 | 0.533 | DNA directed DNA polymerase inhibitor | 0.533 0.073 DBMET00463 | DBMET00463 | |
| 0.104 | 0.184 | 0.146 | Death-associated protein kinase 1 inhibitor | 0.146 0.046 DBMET00463 | DBMET00463 | |
| 0.076 | 0.196 | 0.181 | Psychostimulant | 0.181 0.092 DBMET00463 | DBMET00463 | |
| 0.011 | 0.159 | 0.031 | Phosphodiesterase 6A inhibitor | 0.031 0.006 DBMET00463 | DBMET00463 | |
| 0.039 | 0.223 | 0.096 | Bronchodilator | 0.096 0.069 DBMET00463 | DBMET00463 | |
| 0.01 | 0.206 | 0.076 | Phosphodiesterase 6B inhibitor | 0.076 0.004 DBMET00463 | DBMET00463 | |
| 0.125 | 0.341 | 0.201 | Apoptosis antagonist | 0.201 0.178 DBMET00463 | DBMET00463 | |
| 0.009 | 0.237 | 0.041 | Phosphodiesterase 3B inhibitor | 0.041 0.034 DBMET00463 | DBMET00463 | |
| 0.019 | 0.248 | 0.076 | Phosphodiesterase V inhibitor | 0.076 0.045 DBMET00463 | DBMET00463 | |
| 0.009 | 0.239 | 0.04 | Phosphodiesterase 6H inhibitor | 0.04 0.004 DBMET00463 | DBMET00463 | |
| 0.009 | 0.239 | 0.04 | Phosphodiesterase 6G inhibitor | 0.04 0.004 DBMET00463 | DBMET00463 | |
| 0.018 | 0.263 | 0.072 | Phosphodiesterase 5A inhibitor | 0.072 0.047 DBMET00463 | DBMET00463 | |
| 0.021 | 0.348 | 0.072 | Phosphodiesterase 6C inhibitor | 0.072 0.004 DBMET00463 | DBMET00463 | |
| 0.027 | 0.544 | 0.137 | Nav1.1 sodium channel blocker | 0.137 0.039 DBMET00463 | DBMET00463 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |